Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
2001
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models
2012
Application of newer clearance techniques for the determination of glomerular filtration rate
1998
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Myocarditis
2011 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Alzheimer's disease
2016 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease
2005
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications
2007
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
22q11.2 deletion syndrome
2015 Standout
Measured GFR as a Confirmatory Test for Estimated GFR
2009
Chronic Kidney Disease
2016 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Delivering nanomedicine to solid tumors
2010 Standout
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Predicting Alzheimer disease from a blood-based biomarker profile
2016 StandoutNobel
Myocarditis
2006 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Standards of laboratory practice: cardiac drug monitoring
1998
Nanoparticles for photothermal therapies
2014 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
What is a representative brain? Neuroscience meets population science
2013
AnFgf8mouse mutant phenocopies human 22q11 deletion syndrome
2002 StandoutNobel
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Estimating Glomerular Filtration Rate in Older People
2014
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: Epidemiology and predictors of chronic disease
2005
Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease.
1998
Works of Anna M. Hedman being referenced
Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies
2011
Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden
1997
Biological age is increased by stress and restored upon recovery
2023
Plasma and renal clearance of iohexol–a study on the reproducibility of a method for the glomerular filtration rate
1990
Inhibition by basic drugs of digoxin secretion into human bile
1992